Medicare AdvantageCoverageMedium impact
Relizorb
Blue Cross Blue Shield of Rhode Island·RI · Gastroenterology, Critical Care·Physician / Facility
Effective date
Nov 1, 2019
We identified it
Jun 20, 2026
Summary
Effective November 1, 2019, Relizorb (digestive enzymes added to enteral formula via cartridge device) is not covered for BlueCHiP Medicare products and considered not medically necessary for commercial products due to insufficient evidence. Claims for this technology will be denied.
Action Required
Immediately: Stop submitting claims for Relizorb digestive enzyme cartridge devices for all BlueCHiP Medicare and commercial products. Update billing system to flag these services as non-covered. Notify providers that alternative treatments must be considered for patients requiring digestive enzyme supplementation with enteral feeding.